UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): April 15, 2005


                           SAFETEK INTERNATIONAL, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


          Delaware                        33-22175               75-2226896
----------------------------            ------------         -------------------
(State or other jurisdiction            (Commission            (IRS Employer
      of incorporation)                 File Number)         Identification No.)


                                5509 11th Avenue
                               Brooklyn, NY 11219
                    ----------------------------------------
                    (Address of principal executive offices)


                                  718-383-5255
              ----------------------------------------------------
              (Registrant's telephone number, including area code)


          -------------------------------------------------------------
          (Former name or former address, if changed since last report)
<PAGE>

Section 5 Corporate Governance and Management

Item 5.02 Departure of Directors or Principal  Officers;  Election of Directors;
Appointment of Principal Officers.

On April 15, 2005,  Mr. Shmuel  Shneibalg,  who had been serving as the director
and  as  the  Chairman,  Chief  Executive  Officer,  and  Secretary  of  Safetek
International,  Inc.  (the  "Registrant"),  resigned  from all his  positions as
director and officer of the Registrant.

On April 15, 2005,  Mr. Shay  Goldstein was appointed as the director and as the
Chairman,  Chief  Executive  Officer,  and  Secretary  of  the  Registrant.  Mr.
Goldstein is not a director in any other reporting company.  Mr. Goldstein has a
Doctor of  Medicine  degree  from the Israel  Institute  of  Technology  and has
extensive experience in the development,  financing, and marketing of businesses
involved in the life science and medical  technology  industries.  Between April
2003 and January 2005, Mr.  Goldstein was the manager of the marketing  programs
of Rimed Ltd., an  Israeli-based  company that specializes in the development of
advanced neuro-diagnostic medical equipment.  Between February 2004 and February
2005,  Mr.  Goldstein  was a  consultant  to Silicom  Ventures,  a company  that
provides  financing  to  businesses  involved  in the life  science  and medical
technologies industries. Between June 2002 and September 2003, Mr. Goldstein was
the manager of the business development and marketing programs of Medidactic, an
Israeli-based company that provides marketing services to businesses involved in
the life science and medical technology  industries.  Between September 2001 and
June 2002,  Mr.  Goldstein  was the  manager  of the  business  development  and
marketing  programs of Medidactic.  Ltd, an Israeli-based  company that provides
marketing and training  services to businesses  involved in the life science and
medical  technology  industries.  Between  December  2000 and August  2001,  Mr.
Goldstein was the manager and a co-founder of Renaissance  Biomedical Solutions,
an Israeli-based  company involved in the development of a biochemical  delivery
system for the treatment of  neurodegenerative  diseases.  Between July 1999 and
December 2000, Mr.  Goldstein was a doctor at the Israel  National  Institute of
Forensic Medicine.

Section 9-Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

      (a)   Financial Information.              Not applicable

      (b)   Pro forma financial information.    Not applicable

      (c)   Exhibits.                           Not applicable
<PAGE>

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                       SAFETEK INTERNATIONAL, INC.
                                       (Registrant)


                                       By:    /s/ Shay Goldstein
                                              ----------------------------------
                                       Name:  Shay Goldsten,
                                       Title: Chairman, Chief Executive Officer,
                                              Secretary, and Director

Date: April 19, 2005
{"company-data": {"conformed-name": "SAFETEK INTERNATIONAL INC", "cik": "0000833080", "assigned-sic": "3080", "irs-number": "752226896", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "033-22175", "film-number": "05759496"}, "business-address": {"street1": "5509 11TH AVENUE", "city": "BROOKLYN", "state": "NY", "zip": "11219", "phone": "7025588202"}, "mail-address": {"street1": "5509 11TH AVENUE", "city": "BROOKLYN", "state": "NY", "zip": "11219"}, "former-company": {"former-conformed-name": "THEORETICS INC", "date-changed": "19890718"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): April 15, 2005

                           SAFETEK INTERNATIONAL, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                        33-22175               75-2226896
----------------------------            ------------         -------------------
(State or other jurisdiction            (Commission            (IRS Employer
      of incorporation)                 File Number)         Identification No.)

                                5509 11th Avenue
                               Brooklyn, NY 11219
                    ----------------------------------------
                    (Address of principal executive offices)

                                  718-383-5255
              ----------------------------------------------------
              (Registrant's telephone number, including area code)

          -------------------------------------------------------------
          (Former name or former address, if changed since last report)
Section 5 Corporate Governance and Management

Item 5.02 Departure of Directors or Principal  Officers;  Election of Directors;
Appointment of Principal Officers.

On April 15, 2005,  Mr. Shmuel  Shneibalg,  who had been serving as the director
and  as  the  Chairman,  Chief  Executive  Officer,  and  Secretary  of  Safetek
International,  Inc.  (the  "Registrant"),  resigned  from all his  positions as
director and officer of the Registrant.

On April 15, 2005,  Mr. Shay  Goldstein was appointed as the director and as the
Chairman,  Chief  Executive  Officer,  and  Secretary  of  the  Registrant.  Mr.
Goldstein is not a director in any other reporting company.  Mr. Goldstein has a
Doctor of  Medicine  degree  from the Israel  Institute  of  Technology  and has
extensive experience in the development,  financing, and marketing of businesses
involved in the life science and medical  technology  industries.  Between April
2003 and January 2005, Mr.  Goldstein was the manager of the marketing  programs
of Rimed Ltd., an  Israeli-based  company that specializes in the development of
advanced neuro-diagnostic medical equipment.  Between February 2004 and February
2005,  Mr.  Goldstein  was a  consultant  to Silicom  Ventures,  a company  that
provides  financing  to  businesses  involved  in the life  science  and medical
technologies industries. Between June 2002 and September 2003, Mr. Goldstein was
the manager of the business development and marketing programs of Medidactic, an
Israeli-based company that provides marketing services to businesses involved in
the life science and medical technology  industries.  Between September 2001 and
June 2002,  Mr.  Goldstein  was the  manager  of the  business  development  and
marketing  programs of Medidactic.  Ltd, an Israeli-based  company that provides
marketing and training  services to businesses  involved in the life science and
medical  technology  industries.  Between  December  2000 and August  2001,  Mr.
Goldstein was the manager and a co-founder of Renaissance  Biomedical Solutions,
an Israeli-based  company involved in the development of a biochemical  delivery
system for the treatment of  neurodegenerative  diseases.  Between July 1999 and
December 2000, Mr.  Goldstein was a doctor at the Israel  National  Institute of
Forensic Medicine.

Section 9-Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

      (a)   Financial Information.              Not applicable

      (b)   Pro forma financial information.    Not applicable

      (c)   Exhibits.                           Not applicable
SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                       SAFETEK INTERNATIONAL, INC.
                                       (Registrant)

                                       By:    /s/ Shay Goldstein
                                              ----------------------------------
                                       Name:  Shay Goldsten,
                                       Title: Chairman, Chief Executive Officer,
                                              Secretary, and Director

Date: April 19, 2005